NCT00661999
- Conditions
- Amyloidosis, Anemia, Blood Protein Disorders, +72 more
- Locations
-
- Mayo Clinic in Arizona Scottsdale, Arizona, United States
- Mayo Clinic Rochester, Minnesota, United States
Clinical trial condition
Hypergammaglobulinemia
Explore clinical trials studying Hypergammaglobulinemia. Study availability and eligibility vary by location and protocol.
136 public trials
35 recruiting studies
Hypergammaglobulinemia trial results
NCT00002504
- Conditions
- Amyloidosis, Blast Crisis, Blood Coagulation Disorders, +84 more
- Locations
-
- Hoag Memorial Hospital Presbyterian Newport Beach, California, United States
- Bloomington Hospital Bloomington, Indiana, United States
- St. Vincent Hospital and Health Care Center Research Department Indianapolis, Indiana, United States
- Bergan Mercy Medical Center Omaha, Nebraska, United States
NCT00003331
- Conditions
- Amyloidosis, Blast Crisis, Blood Coagulation Disorders, +84 more
- Locations
-
- Kaplan Cancer Center New York, United States
NCT00005804
- Conditions
- Amyloidosis, Blast Crisis, Blood Coagulation Disorders, +93 more
- Locations
-
- Fred Hutchinson Cancer Research Center Seattle, Washington, United States
NCT00003082
- Conditions
- Amyloidosis, Blast Crisis, Blood Coagulation Disorders, +84 more
- Locations
-
- Arizona Cancer Center Tucson, Arizona, United States
Active, Not Recruiting
Lenalidomide or Observation in Treating Patients With Asymptomatic High-Risk Smoldering Multiple Myeloma
NCT01169337
- Conditions
- Blood Protein Disorders, Hematologic Diseases, Hemic and Lymphatic Diseases, +8 more
- Locations
-
- Alaska Breast Care and Surgery LLC Anchorage, Alaska, United States
- Alaska Women's Cancer Care Anchorage, Alaska, United States
- Anchorage Oncology Centre Anchorage, Alaska, United States
- Katmai Oncology Group Anchorage, Alaska, United States
Active, Not Recruiting
Pembrolizumab in Treating Patients With Intermediate or High-Risk Smoldering Multiple Myeloma
NCT02603887
- Conditions
- Blood Protein Disorders, Hematologic Diseases, Hemic and Lymphatic Diseases, +8 more
- Locations
-
- M D Anderson Cancer Center Houston, Texas, United States
Active, Not Recruiting
Lenalidomide in Treating Patients With Multiple Myeloma Undergoing Autologous Stem Cell Transplant
NCT00114101
- Conditions
- Blood Protein Disorders, Cardiovascular Diseases, DS Stage I Multiple Myeloma, +19 more
- Locations
-
- Mayo Clinic in Arizona Scottsdale, Arizona, United States
- City of Hope Comprehensive Cancer Center Duarte, California, United States
- University of California Davis Comprehensive Cancer Center Sacramento, California, United States
- UC San Diego Medical Center - Hillcrest San Diego, California, United States
Active, Not Recruiting
Early Detection of Multiple Myeloma to Fight Cancer Disparities: A Screening and Patient Navigation Program
NCT05831358
- Conditions
- Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +16 more
- Locations
-
- Cleveland Clinic Taussig Cancer Institute, Case Comprehensive Cancer Center Cleveland, Ohio, United States
Active, Not Recruiting
Zanubrutinib Treatment in Patients With IgM Monoclonal Gammopathy and Antri-MAG Related Polyneuropathy
NCT05939037
- Conditions
- Blood Protein Disorders, Hematologic Diseases, Hemic and Lymphatic Diseases, +6 more
- Locations
-
- University Medical Center Utrecht Utrecht, Netherlands